How Do Bisphosphonates Inhibit Bone Metastasis In Vivo
Bisphosphonates are potent inhibitors of osteoclast-mediated bone resorption and have demonstrated clinical utility in the treatment of patients with osteolytic bone metastases. They also exhibit direct antitumor activity in vitro and can reduce skeletal tumor burden and inhibit the formation of bo...
Main Authors: | Pierrick G. Fournier, Verena Stresing, Frank H. Ebetino, Philippe Clezardin |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2010-07-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558610800314 |
Similar Items
-
Bisphosphonate-Related Osteonecrosis of the Jaw Mimicking Bone Metastasis
by: Geetika Bhatt, et al.
Published: (2014-01-01) -
The role of osteoclasts in breast cancer bone metastasis
by: François Le Pape, et al.
Published: (2016-09-01) -
Bisphosphonate use in the horse: what is good and what is not?
by: Alexis Mitchell, et al.
Published: (2019-06-01) -
Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis
by: Michael Pazianas, et al.
Published: (2010-07-01) -
Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis
by: Pazianas, Michael, et al.
Published: (2010)